Приказ основних података о документу
Computer-aided drug design of MAPK inhibitors by combined 3D-QSAR analysis and molecular docking
dc.creator | Čebzan, Alen | |
dc.creator | Ružić, Dušan | |
dc.creator | Nikolić, Katarina | |
dc.date.accessioned | 2023-08-02T08:42:32Z | |
dc.date.available | 2023-08-02T08:42:32Z | |
dc.date.issued | 2023 | |
dc.identifier.uri | https://farfar.pharmacy.bg.ac.rs/handle/123456789/4952 | |
dc.language.iso | en | sr |
dc.publisher | European Association for Cancer Research | |
dc.rights | restrictedAccess | sr |
dc.source | EACR-Boehringer Ingelheim Drugging and Regulating the MAP Kinase Pathway Virtual Event, Worldwide : 21 - 22 February 2023 | sr |
dc.subject | 3D-QSAR model | sr |
dc.subject | MAPK inhibitors | sr |
dc.subject | descriptors | sr |
dc.subject | docking | sr |
dc.subject | pyrimidine — pyridone | sr |
dc.subject | pyrazolyl-pymole | sr |
dc.subject | ligand | sr |
dc.subject | Bebpebed bal inin based | sr |
dc.subject | structure based | sr |
dc.subject | cancer | sr |
dc.title | Computer-aided drug design of MAPK inhibitors by combined 3D-QSAR analysis and molecular docking | sr |
dc.type | conferenceObject | sr |
dc.rights.license | ARR | sr |
dc.identifier.rcub | https://hdl.handle.net/21.15107/rcub_farfar_4952 | |
dc.type.version | publishedVersion | sr |